NO122281B - - Google Patents
Download PDFInfo
- Publication number
- NO122281B NO122281B NO0372/69A NO37269A NO122281B NO 122281 B NO122281 B NO 122281B NO 0372/69 A NO0372/69 A NO 0372/69A NO 37269 A NO37269 A NO 37269A NO 122281 B NO122281 B NO 122281B
- Authority
- NO
- Norway
- Prior art keywords
- urine
- test
- detection
- glucose
- paper
- Prior art date
Links
- 238000001514 detection method Methods 0.000 claims description 23
- 210000002700 urine Anatomy 0.000 claims description 22
- 235000000346 sugar Nutrition 0.000 claims description 13
- 238000005342 ion exchange Methods 0.000 claims description 10
- 150000008163 sugars Chemical class 0.000 claims description 8
- 239000002250 absorbent Substances 0.000 claims description 6
- 230000002745 absorbent Effects 0.000 claims description 6
- 210000001124 body fluid Anatomy 0.000 claims description 5
- 239000010839 body fluid Substances 0.000 claims description 5
- 108010015133 Galactose oxidase Proteins 0.000 claims description 3
- 102000003992 Peroxidases Human genes 0.000 claims description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 3
- 108010015776 Glucose oxidase Proteins 0.000 claims description 2
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 229940039227 diagnostic agent Drugs 0.000 claims description 2
- 239000000032 diagnostic agent Substances 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 16
- 239000008103 glucose Substances 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 8
- 235000010323 ascorbic acid Nutrition 0.000 description 7
- 229960005070 ascorbic acid Drugs 0.000 description 7
- 239000011668 ascorbic acid Substances 0.000 description 7
- 239000011888 foil Substances 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- 230000002452 interceptive effect Effects 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- -1 hydroxy- Chemical class 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 150000002431 hydrogen Chemical group 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 208000019206 urinary tract infection Diseases 0.000 description 3
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010018473 Glycosuria Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 230000035780 glucosuria Effects 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 201000004538 Bacteriuria Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000004890 Hydrophobing Agent Substances 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 238000013494 PH determination Methods 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000012931 Urologic disease Diseases 0.000 description 1
- AIAOYODCGDSPOP-UHFFFAOYSA-M [Cl-].C1(=CC=CC=C1)N1N(N=[N+](C1)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound [Cl-].C1(=CC=CC=C1)N1N(N=[N+](C1)C1=CC=CC=C1)C1=CC=CC=C1 AIAOYODCGDSPOP-UHFFFAOYSA-M 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000002344 aminooxy group Chemical group [H]N([H])O[*] 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 150000001555 benzenes Chemical group 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000003841 chloride salts Chemical group 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 125000001841 imino group Chemical class [H]N=* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
- B01J41/08—Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
- B01J41/12—Macromolecular compounds
- B01J41/16—Cellulose or wood; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19681698186 DE1698186C3 (de) | 1968-02-02 | 1968-02-02 | Diagnostisches Mittel zum störungsfreien Nachweis von Zuckern in Körper· flüssigkeiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO122281B true NO122281B (enExample) | 1971-06-07 |
Family
ID=5688042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO0372/69A NO122281B (enExample) | 1968-02-02 | 1969-01-31 |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | AT288602B (enExample) |
| BE (1) | BE727746A (enExample) |
| CH (1) | CH511436A (enExample) |
| FR (1) | FR2001200A1 (enExample) |
| GB (1) | GB1193594A (enExample) |
| IL (1) | IL31532A0 (enExample) |
| NL (1) | NL6901608A (enExample) |
| NO (1) | NO122281B (enExample) |
-
1969
- 1969-01-30 CH CH147569A patent/CH511436A/de not_active IP Right Cessation
- 1969-01-31 FR FR6902036A patent/FR2001200A1/fr active Pending
- 1969-01-31 NL NL6901608A patent/NL6901608A/xx unknown
- 1969-01-31 AT AT99369A patent/AT288602B/de not_active IP Right Cessation
- 1969-01-31 NO NO0372/69A patent/NO122281B/no unknown
- 1969-01-31 BE BE727746D patent/BE727746A/xx unknown
- 1969-01-31 GB GB5371/69A patent/GB1193594A/en not_active Expired
- 1969-01-31 IL IL31532A patent/IL31532A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2001200A1 (enExample) | 1969-09-26 |
| BE727746A (enExample) | 1969-07-31 |
| AT288602B (de) | 1971-03-10 |
| NL6901608A (enExample) | 1969-08-05 |
| IL31532A0 (en) | 1969-03-27 |
| GB1193594A (en) | 1970-06-03 |
| DE1698186B2 (de) | 1973-09-06 |
| DE1698186A1 (de) | 1972-01-20 |
| CH511436A (de) | 1971-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Witteman et al. | Relation of moderate alcohol consumption and risk of systemic hypertension in women | |
| Haas et al. | Physiological alterations of vegetative microorganisms resulting form chlorination | |
| Askar et al. | Quality assurance in tropical fruit processing | |
| US4562043A (en) | Self-contained swab cartridge apparatus for detecting occult blood | |
| JP2831474B2 (ja) | サルモネラ菌の同定法および培地 | |
| NO159562B (no) | Reagens for anvendelse ved bestemmelse av glukose ifluida. | |
| PT95633B (pt) | Processo de preparacao de reagentes para a deteccao de microorganismos e de deteccao dos microorganismos com aqueles reagentes | |
| Scherstén et al. | Screening for bacteriuria with a test paper for glucose | |
| Hentges | Inhibition of Shigella flexneri by the normal intestinal flora I. Mechanisms of inhibition by Klebsiella | |
| GB1566856A (en) | Process and reagent for the determination of ascorbic acid | |
| Gilbert et al. | Serological detection of enterotoxin in foods implicated in staphylococcal food poisoning | |
| Chiesa et al. | Procalcitonin in pediatrics: overview and challenge | |
| NO122281B (enExample) | ||
| Hoskins et al. | Leukocyte esterase activity in human amniotic fluid for the rapid detection of chorioamnionitis | |
| Caldwell et al. | Communications: Tolerance of Rainbow Trout to dissolved oxygen supplementation and a Yersinia ruckeri challenge | |
| Jaiswal | Bacteriological study of urinary tract infection in male patients undergoing dialysis due to chronic kidney disease in tertiary care hospitals in Nepal | |
| Simmons | An automated method for serum bilirubin determination | |
| Workman et al. | Activity of penicillinase in Staphylococcus aureus as studied by the iodometric method | |
| Lie | Evaluation of a nitrite test kit (Stat-test) for the detection of significant bacteriuria | |
| Knaysi et al. | The growth of Bacillus megatherium in relation to the oxidation-reduction potential and the oxygen content of the medium | |
| Kleiber et al. | Bloat in cattle and composition of rumen gases | |
| JP3651705B2 (ja) | 採尿用シート及び尿中の成分の検出法 | |
| Allen et al. | Urinary phenylpyruvic acid in phenylketonuria | |
| JPS62147360A (ja) | 亜硝酸塩測定用試薬組成物 | |
| Ostrow | Tests for fecal occult blood |